SELENIUM IN HUMAN HEALTH AND DISEASE: A REVIEWSELENIUM IN HUMAN HEALTH AND DISEASE: A REVIEW.
Selenium is an essential trace element for humans and animals, and selenium deficiency is associated with several disease conditions such as immune impairment. Free radicals are produced in the body as a result of many biochemical processes in the body. All aerobic organisms possess antioxidant defense system to combat oxidative stress. Selenium is an important constituent of antioxidant enzymes, especially, glutathione peroxidase and some other selenoproteins that participate in various physiological activities and protects the cell against the deleterious effects of free radicals by modulating the cell response. However, their exact role is still unknown. Moreover, many human diseases are related to the cell cycle regulation. Selenium intakes, greater than the recommended daily allowance (RDA), appear to protect against certain types of cancers by finding its role in regulation of cell proliferation and apoptosis.
The role of selenium has been explored in normal thyroid functioning, enhancing immune function, carcinogenesis, cardiovascular diseases, in the prevention of pre-eclampsia, diabetes mellitus and male re- production etc. This article reviews introductory aspects of selenium as an essential micronutrient, different sources of selenium, Pharmacokinetics and its role in various pathologies and aims to provide an update on selenium profile.
Key Words: Selenium, Selenoprotein, Glutathione peroxidase, Free Radicals, Antioxidant, Apoptosis
Selenium (Se), a trace mineral, is the 34th element in the periodic table. It is a non metal and its properties are intermediate between adjacent sulfur and tellurium. It was originally discovered by a German chemist Martin Heinric Klaproth, but misidentified as tellurium. Later, in 1818 a Swedish chemist Jons Jacob Berzelius discovered selenium. He named it selenium from Selene, the Greek goddess for moon1. Interest in selenium and health was focused primarily on the potentially toxic effects of high intakes in humans, stimulated by reports of alkali disease in livestock raised in seleniferous areas, in the last century2. The Nutritional significance of Se was established in 1957, when Schwarz and Foltz identified Se as essential for animal health as they discovered that trace amounts of selenium protected against liver necrosis in vitamin E deficient rats and established its nutrient significance3. Since its discovery, Se has been a substrate for extensive research.
In humans, it is well established that Se plays an important role in different physiological processes and its altered levels have direct impact on health leading to development of diseases4.
Selenium occurs in both organic and inorganic forms. Selenide is found frequently in the food supply among the inorganic forms (selenite, selenate or selenide) and these selenates and selenites are reduced to selenide in the liver with end products as dimethyl and trimethyl selenide5. The organic form includes selenome-thionine and selenocystein which are found predominantly in plants and animals respectively. Plant foods are the major sources of selenium in most countries throughout the world. The selenium (Se) content of plants varies tremendously according to its concentration in soil which varies regionally. Plants convert Se mainly into Se-methionine (Se-Met) and incorporate it into protein in place of methionine (Met).
Se-Met can account for greater than 50% of the total Se content of the plant whereas, selenocystine(Se-Cys), methyl-Se-Cys and c-glutamyl-Se-methyl- Cys are not significantly incorporated into plant protein and are at relatively low levels irrespective of soil Se content. Higher animals are unable to synthesize Se-Met and only Se-Cys was detected in rats supplemented with Se as selenite . Animals that eat grains or plants that were grown in selenium rich soil have higher levels of selenium in their muscle.
It is widely distributed in all the tissues; highest concentrations are found in the liver, kidney, heart, spleen and fingernails whereas dairy products, fruits and vegetables are relatively poor sources of selenium (Figure 1).
Se is present in foods like butter, eggs, brewer's yeast, wheat germ, garlic, grains, sunflower seeds, Brazil nuts, walnuts, raisins, liver, shellfish, fresh-water and salt-water fish, Broccoli, fennel seed, ginseng, raspberry leaf, radish, horseradish, onion and shiitake mushrooms6.
ABSORPTION, DISTRIBUTION METABOLISM AND EXCRETION
Selenium compounds are generally very efficiently absorbed by humans, and selenium absorption does not appear to be under homeostatic control6. For example, absorption of the selenite form of selenium is greater than 80% whereas that of selenium as selenomethionine or as selenate may be greater than 90%6,7. In mammals, ingested Se-Met is absorbed in the small intestine via the Na+-dependent neutral amino acid transport system8. Data on the nutritional bioavailability of selenium to humans are sparse. Although the proportion of the nutrient absorbed from the gastrointestinal tract is a major determinant (for calcium and zinc), tissue utilization of the absorbed nutrient and renal conservation (Se) are also important factors influencing bioavailability.
Se bioavailability depends on the conversion of absorbed Se into a biologically active form and tissue retention9. However, because tRNAMet does not discriminate between Met and Se-Met, a greater percentage of Se-Met is incorporated non-specifically into body proteins in place of Met in low Met diet10. Selenium levels in blood and tissues are very much influenced by dietary selenium intake. Normal blood level varies from 0.05 to 0.34 ug/ml. In selenium deficient areas of China, blood levels are as low as 0.009 ug/ml.
Total body selenium has been estimated to be approximately 4 to 10 mg. Selenium is assimilated more effectively from plant food than animal products but some dietary constituents (vitamin C and vitamin E) generally affect its absorption.
Selenium is absorbed mainly from duodenum and is transported actively across the intestinal brush border11. Selenomethionine and selenocysteine, as obtained from their dietary sources, are probably catabolised to release Se for incorporation into selenoproteins. Selenomethionine can be deposited in tissues and be taken up also by myoglobin, cytochrome C, myosin, aldolase and nucleo-proteins. The main route of selenium excretion is urine and very small amount is excreted through feces and expired air12 (Figure 1). Chronic feeding of inorganic Se compounds ( greater than 5 ppm) can be hepatotoxic and teratogenic in animals and humans. Intake of dietary Se-Met is reflected in the Se-content of human skeletal muscle which may vary according to the population; the highest in Japanese adults (1700 ng/g) and the lowest in New Zealand adults (61 ng/g) and in the populations of Se poor regions.
In plasma, Se is mainly found in the albumin fraction and in erythrocytes, mainly incorporated into hemoglobin11. Se in the form of Se-Met is also significantly retained in proteins in the brain13.
In molecular biology a selenoprotein is any protein that includes a selenocysteine (Se-Cys) amino acid residue11. About 25 different selenocysteine-containing selenoproteins have so far been observed in human cells and tissues. Since lack of selenium deprives the cell of its ability to synthesize selenoproteins, many health effects of low selenium intake are believed to be caused by the lack of one or more specific selenoproteins13.
Papp et al 2007 classified the seleno-proteins on the basis of their determined or potential function (Figure 2). The first identified selenoprotein was glutathione peroxidase 1 (GPx1) and the GPx family subsequently became one of the more fully characterized groups of selenoproteins. In Humans GPx1 through GPx4 and GPx6 are selenocysteine containing enzymes. Iodothyronine deiodinase (DIO) have three subtypes, DIO 1, 2, and 3. The selenoenzyme thioredoxin reductase (TrxR) is involved in disposal of the products of oxidative metabolism and also has three subtypes14.
A summary of some of the selenoproteins is given in the Table 1.
There is heterogeneity in the response of biomarkers towards selenium intake. Plasma, erythrocyte and whole blood selenium, plasma selenoproteins P, and plasma, platelet and whole blood glutathione activity are good biomarkers of selenium status in the body. The usefulness of other potential biomarkers including urinary selenium, plasma T3/T4 ratio, plasma thyroxine, plasma total homocysteine, hair and toenail selenium and muscle glutathione peroxidase activity has not been established. For these potentially useful biomarkers, more information, in terms of effects of varying intakes, duration of intervention, baseline selenium status and effects of genotype, is needed to evaluate their strengths and limitations in different populations39.
SELENIUM AND HEALTH
Today, Selenium deficiency is suggested to implicate in the pathogenesis of wide variety of processes that affect our state of health and longevity. The list of clinical disorders expected to be influenced by Se deficiency is rapidly growing with time. Se deficiency has also been observed during total parentral nutrition (TPN)112. Some selected issues regarding the role of Se in health and disease have been briefly outlined as follows:
In humans, some controversy exists concerning the effects of Se levels on aging. Circulating Se concentrations either fall slightly or remain stable with age. However, the tissue distribution may be altered. The free radical theory of aging40 states that aging is the result of cumulative damage incurred by free radical reactions as well as progressive defects in protection against free radical reactions with the passage of time. Free radical mediated lipid peroxidation in lysosome membrane leak out lysosomal hygrolases which cause dystrophic changes in muscle fibers. As a result, muscles become weak with growing age41. Lipid
Table 1: A Summary of Selenoproteins
###- An antioxidant enzyme, decomposes 1-1202 and
1###Cytosolic GPx (GPx1)###All, including thyroid'6###- Protection against certain cancers
###- Protection against neurodegenerative
###Phospholipid hydroperoxide /###All, including thyroid, sperm###- Metabolism of lipids20
###Sperm capsule selenoprotein###tail'6###- Protective role in cardiovascular diseases
###(GPx4)###- Structural protein in spermatozoa and shields
###developing sperm cells21
###Gastrointestinal GPx (GPx2)###Gastrointestinal tract'6###- Antioxidant
###- Regulating the bioavailability of nitric acid
###Extracellular GPx (GPx3)###Plasma, thyroid'6###produced from platelet and vascular celir
###- Mediator of effects of estrogen in terms of fat
###GPx6###Embryo, olfactory epithelium###- Antioxidant
###- Provides protection to skin from free radicals25
2###Thioredoxin reductase(TrxR)###All, including thyroid'6###- Protein thiol redox regulation
###- Vitamin C recycling and DNasynthesis26
###Iodothyronine-deiodinase (DIO1)###Liver, kidneys, and thyroid'6
3###Iodothyronine-deiodinase (DIO 2)###Central nervous system,
###and pituitary'6###- Synthesis of active thyroid hormone27
###Iodothyronine-deiodinase (DIO 3)###Brown adipose tissue, central
###nervous system, and placenta'6
###- Functions as an antioxidant
###- In the transport of seienium2~
###- Protection against Hepatitis B virus
###X protein induced lipid peroxidation29
5###Selenoprotein w###Muscle, heart, brain, and tongue - Antioxidant
6###Selenoprotein K###Heart, skeletal muscles3'###- Antioxidant
7###Selenoprotein V###Testes24###- Unknown(Suggested redox function)30
8###Selenoprotein S###All###- Regulation of cellular redox balance3
9###Selenoprotein R###Liver and kidney31###- Antioxidant
10###Selenoprotein M###Brain, thyroid33###- Redox function23
###Brain, lung, testis, liver,
11###Selenoprotein 15###- Regulation of apoptosis38
###thyroid, and Kidney34
###Skeletal Muscles, brain,###- Presumably regulates calcium channels in redox
###lung and placenta35
13###Selenophosphate Synthetase 2(SPS2)###All23###- Biosynthesis of selenocysteine36
peroxidation and accumulation of carbonyl moieties on protein are produced by oxidative stress. Mitochondria accumulate age-related damage, releasing more reactive oxygen species.
Thus, GPx and other selenoproteins may play a role in slowing cellular damage and the aging process by scavenging free radicals42. GPx, a selenium containing antioxidant enzyme which scavenges H2O2 and prevents the initiation of free radical chain reaction, has been theorized to extend life span and prevent age related functional disorders. Selenium deficiency plays a crucial role in causing or aggravating anemia and cell destruction as glutathione peroxidase protects red blood cells from free radical damage and destruction. Ji et al also observed the age related decline in GPx activity and its impact on the genesis of various diseases43. Moreover, the efficiency of the immune system declines with age.
In humans, low Se status in the elderly was correlated with lower triiodothyrinine to thyroxine ratios due to the raised thyroxine concentrations. Se supplementation decreased the serum thyroxine concentration44. A deficiency in thyroxine to triiodothyrinine conversion will affect general metabolism including immunity45-48. Finally,telomere length decreases with age in peripheral leukocytes and is accelerated by oxidative stress in fibroblasts. The rate of telomere shortening and carbonyl group accumulation wasinversely correlated with GPx activity in fibroblasts49.
Serum selenium concentration is associated with metabolic factors in the elderly50.
Although the mechanisms involved have yet to be fully elucidated, significant amounts ofSe present in lymph nodes, liver and spleen signify its role in immunity. The effects of Se deficiency can include reduced T-cell counts, impaired lymphocyte proliferation and responsiveness.
Dietary supplementation of humans with 200 mg of sodium selenite enhances T-lymphocyte immune responses53. A progressive decline in plasma Se has been widely reported in adult respiratory distress syndrome(ARDS) and AIDS patients, and approximately parallels T-cell loss or stage of HIV infection. Chronic oxidative stress has been reported during the early and advanced stages of HIV-1 infection. It is particularly noticeable at the terminal stages of disease where Se deficiency is now considered a classical symptom/sign of end stage. There is an extremely high turnover of CD4 T-cells in AIDS, with billions of new cells lost and replaced daily. The constant formation of new cells to replace those lost requires an extremely efficient and effective Se supply to keep up with the high demand in active lymphocytes. Sub-clinical requirement for Se by lymphocytes a n d granulocytes will clearly not be as great when the immune system is not overly stressed.
After selenium supplementation, the range of variation in % change in selenoenzyme activity between individuals may reflect the tocopherol status of the blood cells. Lymphocytes and granulocytes can contain up to 35 times more alpha-tocopherol than red blood cells or platelets, probably reflecting preferential mobilization to cells with different metabolic need. All of these cells are capable of increasing their metabolic activity as a function of their immunosuppressive role. In doing so, membrane sensitive oxidases are generated which oxidise NADH and NADPH thereby increasing O2 utilization and its subsequent reduction to reactive oxygen species (ROS). Tocopherol and Se supply to these cells is therefore essential to provide controlover their functional generation of excessive ROS54.
Evidence of an extended role of GPx4 beyond that of an antioxidant comes from the work of We it zel and We n del (1993)55, who have demonstrated that GPx4 regulates the activity of lymphocyte 5-lipoxygenase, and Steinhilber D et al56, who show that GPx4 supresses 5 - lypoxy genase activity in lymphocytes and granulocytes. Consequently, GPx 4 may have a regulatory role in the inflammatory response through suppression of lypoxygenase catalysed leukotriene biosynthesis from arachidonic acid.
Moreover, it has been hypothesised that vitamin E may have a regulatory influence over leukotriene biosynthesis as a substrate for both n-6 and n-3 unsaturated fatty acid desaturase enzymes57. This indication, that functional selenium and vitamin E status may influence leucotriene metabolism, has important implications in relation to chronic inflammatory disease, particularly asthma which is now the most prevalent chronic inflammatory condition in childhood, and has doubled over the last 20 years in the UK. There is a dramatic rise in the prevalence of asthma in the UK which mirrors the dramatic decline in blood Se concentration.
This situation has the potential to exacerbate the recognized as involved in the pathogenesis of the disease. Moreover, Se status is decreased in patients with asthma, as is activity of glutathione peroxidase in platelets and erythrocytes. There is an associated marked oxidant/antioxidant imbalance in the blood of asthmatics, which reflects poor antioxidant status and enhanced inflammatory mediated oxidative stress58.
According to the University of Maryland Medical Center, a 2004 study of 24 asthmatics that were given selenium supplements for 14 weeks had significant improvement in their symptoms when compared to a control group given a placebo. Although this is a small study done over a short amount of time, it's encouraging59.
The evidence supporting an effect of selenium on the risk of diabetes is variable, occasionally conflicting, and limited to very few human studies. Following a trial investigating the effect of selenium supplementation (200?ug/day) on skin cancer, subsequent analysis showed that there was an increased risk of developing type 2 diabetes in the supplemented group60. Evidence from analysis of NHANES III61 supports these findings; the adjusted mean serum selenium concentrations were slightly, but significantly, higher in diabetics compared with those without the disease. This study, conducted in an elderly French population, found a sex-specific protective effect of higher selenium status at baseline on later occurrence of dysglycemia; that is, risk of dysglycemia was significantly lower in men with plasma selenium in the highest tertile compared with those in the lowest tertile (14.21-78. 96 - ng/ml) (HR: 0.48, 95% CI: 0.25-0.92), but no significant relationship was observed in women62.
Cross-sectional case-control analyses have also given mixed results. A number of studies have found a lower selenium status in diabetic patients compared with controls63,64 , which is in contrast to the findings from the NHANES III analysis61-65. Analysis of the Health Professionals Follow-up Study found the prevalence of diabetes to be greater in men with the lowest tertile of toenail selenium (OR: 0.43, 95% CI: 0.28-0.64) compared with the highest tertile66. The study also analyzed men with both diabetes and CVD compared with controls, but no association was found. Due to the global variations in selenium status these studies may not be directly comparable, and the results may in fact indicate a U-shaped risk curve, which could be further complicated by other diseases associated with diabetes.
The mechanisms behind this potential U-shaped risk association have not yet been clearly defined. In its role as an antioxidant, particularly within the GPxs, selenium is likely to be important in reducing oxidative stress, an important risk factor for developing diabetes. There are also plausible suggestions that selenium can influence glucose metabolism. However, at high intakes it is also conceivable that reactive oxygen species could be generated or selenium may accumulate in the organs associated with glucose metabolism69. In patients with diabetes, selenium supplementation (960ug/day) reduced NF-?B levels to those comparable with nondiabetic controls67. Animal model work has also suggested a role for selenium supplementation in reducing some biochemical effects of diabetes. The study also suggested that treatment with selenium may influence aspects of other chronic diseases associated with diabetes, for example, by decreasing the levels of serum markers of liver damage.
Expression of SelS was found to be significantly lower in diabetic rats in a fed state compared with normal control animals and appears to be regulated by glucose. Whatever the mechanisms responsible, current evidence implies that both low and high selenium intakes could influence the risk of diabetes, and this relationship requires further investigation through good quality human studies68.
Chronic oxidative stress has been reported during the early and advanced stages of HIV-1 infection70 . Oxidative stress has been linked to HIV-induced apoptosis of T lymphocytes71 , to alterations in the HIV promoter that may produce progression to AIDS in patients with latent HIV72 and to the development of AIDS Kaposi sarcoma73.
It has also been identified as one of the factors that may lead to neural damage74. addition, oxidative stress may induce alterations in the interleukin profile, contributing to immune deregulation and increased viral replication during the progression of HIV-1 infection
Selenium and its biologically active compounds play a vital role in maintaining the normal immune system and preventing the alteration in cells, thereby controlling the occurrence and progression of viral infectious disease such as HIV. Biochemical deficiency of vitamins A, B6, B12 and zinc levels has been associated with an increased rate of disease progression while normalization of these levels has been linked to slower disease progression76,77.
In HIV-infected patients, Se deficiency has been significantly correlated with total lymphocyte counts. Plasma Se levels have been positively correlated with CD4 cell counts and CD4/CD8 ratio. Loss of CD4T cells in HIV1 infection was found to be closely associated with depletion in plasma selenium level . It has been suggested that the increased oxidative stress in HIV infection is caused by elevated IL-8 levels which exhausts the inflammatory response79 . Minor concentration of reactive oxygen species induces the expression and replication of HIV in human T cells. This effect is mediated by the activation of NF-KB, transcription factor via HO. In vitro models have shown that Se enhances interleukin-2 production in a dose-dependent manner (the cytokine responsible for the earliest and most rapide xpansion of T lymphocytes). This probably occurs via the increased expression of high-affinity receptors80.
In addition, Se reduces TNF receptors and prevents the adverse effects of high circulating TNF levels including Kaposi's sarcoma. It seems also to suppress TNF induced HIV replication probably through selenoproteins synthesis particularly in the GSH and Trx systems78,81,82. Thus, maintaining an optimal Se status in HIV-1 infected men and women may help to increase the enzymatic defense and improve general health in those patients83,84.
Low blood Se concentrations have been associated with increased cardiovascular disease mortality. In an epidemiological study, an excess of incidence of mortality from ischemic heart disease in eastern Finnish men and women with low serum selenium concentrations was observed, suggesting that low selenium levels have a causal effect indevelopment and deterioration of ischemic heart disease85 . Free radicals are toxic to the myocardium and can cause tissue damage that leads to extensive necrosis, myocytolysis and cellular edema86 Atherosclerotic plaque formation may be a reflection of sub-optimal GPx4 activity in the prevention of LD Loxidatio, with subsequent up take by endothelial cells and macrophages in arterial blood vessels91. Selenium via GPx reduces phospholipids, hydro peroxides and cholestryl esters associated with lipoproteins and may therefore, not only reduce the accumulation of oxidized LDL in arterial wall but also reduce platelet aggregation and activation of monocyte and macrophages87.
Selenium owing to its antithrombotic effect on the interaction between platelets and endothelial cells via GPx, also provides concrete evidence in the prevention of atherosclerosis88.
Kharb, in her study on acute myocardial infarction (AMI) patients, observed that selenium dependent GPx level decreases significantly in AMI patients and explained it as an imperative consequent of GPx activity in annihilating oxygen toxicity by metabolizing H2O2 and inhibiting
Among various antioxidant minerals, selenium t may prove to be of major significance as a prophylactic agent against cancer. Low blood selenium concentration and incidence of carcinognesis have been well observed in both animals92 as well as in human studies93. In addition, it has been demonstrated in a double blind randomized cancer prevention trial in humans that increased selenium intake has a significant role in the treatment of cancer94 . Various investigators have reported the role of selenium as an inhibitor of carcinogenesis in various organs including liver, skin, stomach, mammary gland and oral cavity etc95,96. In vitro and In vivo studies on selenium supplementation also suggested that selenium inhibits cell growth and DNA synthesis in a variety of cell lines leading to the normalization of regulatory pathways that are affected in early stages of carcinogenesis97,98.
Klein et al, on the basis of SELECT (Se and vitamin E cancer prevention trial) in humans, concluded that treatment with a high dose of Se in combination with vitamin E can prevent the incidence of prostrate cancer. This reflects the importance of Se and vitamin E in the etiology of cancer99. Despite numerous investigations regarding the prophylactic of selenium against cancer, the exact mechanism behinds its role is still a matter of debate and needs further investigation. However, in order to explore the hidden mechanism involved in chemopreventive action of selenium, it has been suggested that irrespective of its antioxidant role (as component of GPx enzyme) with optimal selenium concentration, high dose of selenium induces oxidative stress and apoptosis in cancer cell s 102. Furthermore, to emphasize its chemopreventive action, Spray et al have also reported that selenium inactivates the transcription factor NF-KB, thereby leading to inhibition of cell growth100.
Another marked explanation for selenium activity includes its direct role in the liver mixed function oxidase system that is responsible for the metabolism of chemical carcinogens101. Although the mechanism for Se inhibition of carcinogenesis is still unclear, it might be associated with the monomet hylated form of Se that can be metabolized to methylselenol which may provide better cancer protection1 0 3. Other mechanisms proposed for anticancer action of selenium include anti oxidant effects, enhanced carcinogen detoxification, enhanced immune surveillance, modulation of cell proliferation, inhibition of tumour cell invasion, and inhibition of angio-genesis105. There is evidence of anticar-cinogenic activities for several intermediary metabolites of naturally occurring organic and inorganic forms of selenium51.
Seleno protein P transports selenium particularly to testis and brain107. Inactivation of selenoprotein P gene in mice due to selenium deficiency generally effects the normal functioning of testis leading to male infertility106. In addition, testis has the highest selenium concentration among the reproductive organs and studies on GPx activity in humans have revealed that this enzyme is the metabolic mediator of body selenium and protects spermatozoa against pro-oxidant induced death and oxidative injury, which reflect the importance of selenium and its related enzymes during spermatogenesis108. Among the five enzymes of GPx, GPx1 prevents apoptosis induced by oxidative stress and GPx4 acts directly on membrane phospholipid hydroperoxides and detoxifies them. GPx polymerizes to form a structural protein into mitochondrial capsule and oxidative stress1 108. Selenium as GPx, is present in spermatids and forms the structural part in the mid piece of mature spermatozoa.
Some well known effects of selenium deficiency include instability of motility109, low reproductive ability and abnormal development of spermatozoa110. Selenium is also required for testosterone synthesis and sequential development of flagella111. It can restore the physiological constitution of polyunsaturated fatty acid in the cell membrane.
A study on infertile men with unilateral varicocele or genital tract inflammation, showed the observation that glutathione treatment has a statistically significant positive effect on sperm motility, sperm morphology and sperm quality and suggested the therapeutic importance of Glutathione against male infertility113. Testes are extremely resistant to Se depletion and have high Se content. Recent studies have shown that sperm and testicular Se was unaffected by the supplemen-tation, suggesting that testes are protected from Se excess as well as from Se deficiency114.
Pre-eclampsia (pregnancy induced hypertension; PIH), is an important cause of maternal morbidity and mortality with essentially unknown etiology (i.e., the precise factors involved in the pathogenesis of PIH are still unknown)115. It has been conceived that free radical mediated oxidative stress may contribute to the development of pre-eclampsia. Selenium and its related enzymes specially GPx play a crucial role in annihilating oxygen toxicity and there by controlling the progression of disease116. In addition, selenium deficiency in women may result in infertility, miscarriages and retention of the placenta117. Furthermore, Han and Zhon studied the effect of selenium supplement in 52 pregnant women with high risk factors of pregnancy induced hypertension (PIH) and concluded that selenium supplements prevent and decrease the incidence of PIH and gestational edema in pregnant women118.
Selenium deficiency has been observed in patients with severe gastrointestinal disorders. James et al reported that selenium in association with other trace element (Zn, Cu and Mn) perform numerous functions indispensable to maintenance of life, growth and reproduction119. Gastrointestinal problems that impair selenium absorption usually affect absorption of other elements as well and thereby, impair cellular and physiological functions leading to the development of various patho-physiological conditions120.
Aselenoen zyme, Iodothyronine deiodinase, catalyzes the biotransformation of thyroxine (T4) to triiodothyronine (T3)121. These Deiodonases also catalyze the breakdown of T4 to reverse T3, degrade T4 to T2, inactive T3 and regulate the hypothalamic-pituitary-thyroid axis(HPTA)122. Selenomethionine, of which Se is the chief constituent, supplementation produced no clinically significant changes in thyroid hormone concentration123.
KESHAN and KASCHINBECK DISEASE
Previously, it has been reported that selenium deficiency is most commonly seen in the development of two diseases, both of which are only seen in the People's Republic of China, where acutely low soil levels of the element are detected. Keshan disease is a cardiomyopathy of children and young women and manifests as acute or chronic cardiac enlargement and arrhythmia.
Kaschinbeck disease is an osteoarthropathy that occurs mainly in young people. This disease shortens the fingers and long bones with severe enlargement and dysfunction of joints resulting in retardation of growth. Although they are multifactorial in origin, selenium deficiency is a major factor in their etiology and both the diseases are effectively prevented by therapy with selenium supplementation16,124.
Scientific research shows that people with rheumatoid arthritis have low levels of selenium. A study suggests, it is part of the body's defense mechanism. The authors found lower selenium levels in patients with rheumatoid arthritis who were treated with arthritis medication compared with people without the condition125. In people without rheumatoid arthritis or a family history of the condition, low levels of the mineral may increase the risk of developing rheumatoid arthritis126. However, scientific findings supporting the link are conflicting. Further research is necessary to support the use of selenium supplements.
High Se levels in blood can result in a toxic condition called "selenosis". Symptoms of Se toxicity include gastrointestinal upsets, hair loss, white blotchy nails, garlic breath odor, irritability, fatigue and mild nerve damage127. National Academy of Sciences has set a tolerable upper intake level of selenium at 400 micrograms per day for adults to prevent the risk of developing toxicity128.
Selenium has long been a source of concern as a toxic element but research over time has shown that it is vital for human health. Selenium is the chief component of the selenoproteins which exert their major role as antioxidants. An adequate level of body Se status is essential for exerting its beneficial effects. Different biomarkers have been evaluated for the measurement of selenium in the body. Population Selenium levels are different in different geographic areas of the world because of variability in selenium content of soil. Individuals may have differing metabolic needs for selenium, regulated at the level of Se dependent cell function, for example in relation to immuno-responsive roles, depicting pharmacogenetic variability among individuals. Se is necessary for normal human physiology with particular reference to immunity, fertility, thyroid metabolism, cardiovascular system, diabetes mellitus and other inflammatory diseases.
Excess of everything is bad; same is shown in case of Se toxicity. Recent studies do not support, entirely, role of selenium supplementation particularly in selenium replete population, and so this area is open for further research.
Grant Support, Financial Disclosure and Conflict of Interest
1. Kabata-Pedias A. Geochemistry of selenium. J Eviron Pathol Toxicol Oncol 1998:17:173-7.
2. Smith M, Franke KW, Westfall BB. The selenium problem in relation to public health. A preliminary survey to determine the possibility of selenium intoxication in the rural population living in seleniferous soil. US Public Health Rep 1936;51:1496-1505.
3. Schwarz K, Moltz CM. Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J Am Chem Soc 1957;70:3292-3.
4. Rahul S, Geeta J. Selenium and its role in health and disease. Kuwait Med J 2007;39:10-8.
5. Ganther HE, Hsieh HS. Mechanisms for the conversion of selenite to selenides in mammalian tissues. In: Hoekstras WG, Suttie JW, Ganther HE, Mertz W, editors. Trace elements in man and animals. Baltimore: Park Press; 1974. P. 339-46.
6. World Health Organization. Selenium. Geneva: WHO;1987.
7. Patterson BH, Zech LA, Swanson CA, Levander OA. Kinetic modeling of selenium in humans using stable isotope tracers. J Trace Elem Electrolytes Health Dis 1993;7:117-20.
8. Vendeland SC, Deagen JT, Butler JA,Whanger PD. Uptake of selenite, selenomethionine and selenate by brush border membrane vesicles isolated from rat small intestine. Biometals 1994;7:305-12.
9. Levander OA, Alfthan G, Arvilommi H, Gref CG, Huttunen JK, Kataja M, et al Bioavailability of selenium to Finnish men as assessed by platelet glutathione peroxidase activity and other blood parameters. Am J Clin Nutr 1983;37:887-97.
10. Waschulewski IH, Sunde RA. Effect of dietary methionine on tissue selenium and glutathione peroxidase on tissue selenium and glutathione peroxidase activity given selenomethionine. Br J Nutr 1988;60:57-68.
11. Chatterjea MN, Shinde R. Metabolism of minerals and trace elements. In: Chatterjea MN, Shinde R. Text book of medical biochemistry. 5th ed. New Delhi: Jaypee Brothers Med Pub Ltd; 2002. P. 526-31.
12. Ganther HE. Pathways of selenium metabolism including respiratory excretory products. J Am Coll Toxicol 1986;5:1-5.
13. Gronbaek H, Thorlacius-Ussing O. Selenium in the central nervous system of rats exposed to 75-Se selenomethionine and sodium selenite. Biol Trace Elem Res 1992;35:119-27.
14. Susan JFT, Yongping B, Martin RB, Rachel C, Dianne F, John EH, et al Selenium in human health and disease. Antioxid Redox Signal 2011;14:1337-83.
15. Laura VP, Jun L, Arne H, Kum Kum K. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 2007;9:775-806.
16. FAO/WHO. Selenium: human vitamin and mineral requirements. Thailand: FAO/WHO; 2001. p. 194-206.
17. Carlson BA, Xu XM, Gladyshev VN, Hatfield DL. Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J Biol Chem 2005;280:5542-8.
18. Trepanier G, Furling D, Puymirat J, Mirault ME. Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain. Neuroscience 1996;75:231-43.
19. Lindenau J, Noack H, Asayama K, Wolf G. Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in micro glia durin gexcitotox in induced neurodegeneration. Glia 1998;24:252-6.
20. Chen CJ, Huang HS, Chang WC. Depletion of phospholipid hydroperoxide glutathione peroxida seup-regulate sara chidonate metabolism by 12 Slip oxygenase and cyclooxygenase 1 in human epidermoid carcinoma A431 cells. FASEB J 2003;17:1694-6.
21. Ursini F, Heim S, Kiess M, Maiorino M, Roveri A, Wissing J, et al Dual function of the selenoprotein PHGPx during sperm maturation. Science 1999;285:1393-6.
22. Freedman JE, Frei B, Welch GN, Loscalzo J. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest 1995;96:394-400.
23. Reeves MA, Hoffmann PR. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 2009;66:2457-78.
24. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, et al Characterization of mammalian seleno-proteomes. Science 2003;300:1439-43.
25. Schallreuter KU, Wood JM. The role of thioredoxinreductase in the reduction of free radicals at the surface of the epidermis. Biochem Biophys Res Commun 1986;136:630-6.
26. Mustacich D, Garth P. Thioredoxin reductase. Biochem J 2000;346:1-7.
27. Vasudevan DM, Sreekumari S. Mineral metabolism. In: Vasudevan DM, Sreekumari S. Text Book of biochemistry. 3rd ed. New Delhi: Jaypee Brothers Med Pub Ltd; 2001. p. 284-98.
28. Schweizer U, Schomburg L, Savaskan NE. The neurobiology of selenium: lessons from transgenic mice. J Nutr 2004;134:707-11.
29. Yi YS, Park SG, Byeon SM, Kwon YG, Jung G. Hepatitis B virus X protein induces TNF-a expression via down regulation of selenoprotein P in human HePG2. Biochem Biophys Acta 2003;1638:249-56.
30. Dikiy A, Novoselov SV, Fomenko DE, Sengupta A, Carlson BA, Cerny RL, et al SelT, SelW, SelH, and Rdx12: genomics and molecular insights into the functions of selenoproteins of a novel thioredoxin-like family. Biochemistry 2007;46:6871-82.
31. Lu C, Qiu F, Zhou H, Peng Y, Hao W, Xu J, et al Identification and characterization of seleno protein K: anantio xidant in cardiomyocytes. FEBS Lett 2006;580:5189-97.
32. Fomenko DE, Novoselov SV, Natarajan SK, Lee BC, Koc A, Carlson BA, et al Methionine-R-sulfoxide reductase 1 (MsrB1) knockout Mmice: roles of MsrB1 in redox regulation and identification of a novel selenoprotein form. J Biol Chem 2008;284:5986-93.
33. Flanigan KM, Kerr L, Bromberg MB, Leonard C, Tsuruda J, Zhang P, et al Congenital muscular dystrophy with rigid spine syndrome: a clinical, pathological, radiological, and genetic study. Ann Neurol 2000;47:152-61.
34. Shigeta K, Matsumura K, Suzuki Y, Shinohara A, Furuta N. Distribution and dynamic pathway of selenium species in selenium-deficient mice injected with (82)Se-enriched selenite. Anal Sci 2008;24:1117-22.
35. Moghadaszadeh B, Petit N, Jaillard C, Brockington M, Roy SQ, Merlini L, et al Mutations in SEP N1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet 2001;29:17-8.
36. Guimaraes MJ, Peterson D, Vicari A, Cocks BG, Copel and NG, Gilbert DJ, etal Identification of a novel sel D homolog from eukaryotes, bacteria, and archaea: is there an autoregulatory mechanism in selenocysteine metabolism? Proc Natl Acad Sci USA 1996;93:15086-91.
37. Kumar S, Bjornstedt M, Holmgren A. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur J Biochem 1992;207:435-9.
38. Apostolou S, Klein JO, Mitsuuchi Y, Shetler JN, Poulikakos PI, Jhanwar SC, et al Growth inhibition and induction of apoptosis in mesotheli a cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene 2004;23:5032-40.
39. Kate A, Lee H, Linda JH, Rachel H, Amelie C, Susan JF. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 2009:89):2025-39.
40. Harman D. Aging and disease: extending functional lifespan. Ann N Y Acad Sci 1996;786:321-6.
41. Singh S, Saxena R, Lal AM. Influence of aging on plasma ascorbate level. Natl Acad Sci Lett 2005; 28 (3 and 4):125-127.
42. Orr WC, Sohal RS. Extension of life span by over expression of superoxide dismutase and catalase in drosophila melanogaster. Science 1994;263:1128-30.
43. Ji LL, Dilton R, Wu E. Myocardial aging antioxidant enzyme system and related biochemical properties. Am J Physiol 1991; 261:386-90.
44. Olivieri O, Girelli D, Azzini M, Stanzial AM, Russo C, Ferroni M, et al Low selenium status in the elderly influences thyroid hormones. Clin Sci (Lond) 1995;89:637-42.
45. Olivieri O, Girelli D, Stanzial AM, Rossi L, Bassi A, Corrocher R. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res 1996;51:31-41.
46. Ruz M, Codoceo J, Galgani J, Munoz L, Gras N, Muzzo S, et al Single and multiple selenium-zinc-iodine deficiencies affect rat thyroid metabolism and ultrastructure. J Nutr 1999;129:174-80.
47. Savarino L, Granchi D, Ciapetti G, Cenni E, Ravaglia G, Forti P, et al Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/ centenarians. Exp Gerontol 2001;36:327-39.
48. Kauf E, Dawczynski H, Jahreis G, Janitzky E,Winnefeld K. Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital hypothyroidism. Biol Trace Elem Res 1994;40:247-53.
49. SerraV, Grune T, Sitte N, Saretzki G, von Zglinicki T. Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Ann N Y Acad Sci 2000;908:327-30.
50. Yang KC, Lee LT, Lee YS, Huang HY, Chen CY, Huang KC. Serum selenium concentration is associated with metabolic factors in the elderly: a cross sectional study. Nutr Metab (Lond) 2010,7:38
51. Ryan-Harshman M, Aldoori W. The relevance of selenium to immunity, cancer, and infectious inflammatory diseases. Can J Diet Prac Res 2005;66:98-102.
52. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Strotzky G. Supplementation with selenium and human immune cell functions. 2. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 1994;41:115-27.
53. Roy M, Kiremidjian-Schumacher L, Wishe H, Cohen MW, Stotzy G. Supplementation with selenium and human immune cell functions 1. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol Trace Elem Res 1994;41:103-14.
54. KM Brown, JR Arthur.Selenium, selenoproteins and human health: a review. Public Health Nutr 2001;4: 593-9.
55. Weitzel F, Wendel A. Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the per oxidetone.J Biol Chem 1993;268:6288-92.
56. Steinhilber D, Herrmann T, Rothe HJ. Selenium dependent peroxidases suppress 5-lypoxygenase activity in B-lymphocytes and immature myeloid cells. Eur. J Biochem 1996;242:90-7.
57. Infante JP. Vitamin E and selenium participation in fatty acid desaturation: a proposal for an enzymatic function of these nutrients. Mol Cell Biochem 1986;69:93-108.
58. Seaton A, Godden DJ, Brown K. Increase in asthma: a more toxic environment or a more susceptible population. Thorax 1994;49:171-4.
59. University of Maryland. Asthma [Online]. 2011 [cited on August 10, 2011]. Available from URL: http://www.umm.edu/altmed/articles/ asthma-000015.htm [Citation Date=?]
60. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007; 147:217-23.
61. Bleys J, Navas-Acien A, Guallar E. Serum selenium and diabetes in US adults. Diabetes Care 2007;30:829-34.
62. Akbaraly TN, Arnaud J, Rayman MP,Hininger-Favier I, Roussel AM, Berr C, et al Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutr Metab (Lond) 2010;7:21.
63. Kljai K, Runje R. Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res 2001;83:223-9.
64. Navarro-Alarcon M, Lopez-G de la SH, Perez-Valero V, and Lopez-Martinez C. Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci Total Environ 1999;228:79-85.
65. Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003-2004. Environ Health Perspect 2009;117:1409-13.
66. Rajpathak S, Rimm E, Morris JS, Hu F. Toenail selenium and cardiovascular disease in men with diabetes.J Am Coll Nutr 2005;24:250-6.
67. Faure P, Ramon O, Favier A, Halimi S. Selenium supplementation decreases nuclear factor-kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. Eur J Clin Invest 2004;34:475-81.
68. Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, De Silva A, et al Tanis: a link between type 2 diabetes and inflammation? Diabetes 2002;51:1859-66.
69. Bleys J, Navas-Acien A, Guallar E. Selenium and diabetes: more bad news for supplements. Ann Intern Med 2007;147:271-2.
70. Favier A, Sappey C, Leclerc P, Faure P, MicoudM. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994;91:165-80.
71. Dobmeyer TS, Findhammer S, Dobmeyer JM, Klein SA, Raffel B, Hoelzer D, et al Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 1997;22:775-85.
72. Pace GW, Leaf CD. The role of oxidative stress in HIV disease. Free Radic Biol Med 1995;19:523-8.
73. Mallery SR, Bailer RT, Hohl CM, Ng-Bautista CL, Ness GM, Livingston BE, et al Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis. J Cell Biochem 1995;59:317-28.
74. De whurst S, Gelbard HA, FineS M. Neuropathogenesis of AIDS. Mol Med Today 1996;2:16-23.
75. Muller F, Svardal AM, Aukrust P, Berge RK, Ueland PM, Froland SS. Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection. Am J Clin Nutr 1996;63:242-8.
76. Baum MK, Shor-Posner G. Micronutrient status in relationship to mortality in HIV-1 disease. Nutr Rev 1998;56:135-9.
77. Tang AM, Graham NM, Semba RD, Saah AJ. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997;11:613-20.
78. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and in flammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 1997;56:31-41.
79. Moutet M, d'Alessio P, Malette P, DevauxV, Chaudiere J. Glutathione peroxidase mimics prevent TNF-alpha- and neutrophil-induced endothelial alterations. Free Radic Biol Med 1998;25:270-81.
80. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotz ky G. Selenium supplementation enhances the expression of inter leuk in 2 recept orsubunits and internalization of interleukin 2. Proc Soc Exp Biol Med 1993;202:295-301.
81. Haslett PA. Anticytokine approaches to the treatment of anorexia and cachexia. Semin Oncol 1998;25:53-7.
82. Hori K, Hatfield D, Maldarelli F, Lee BJ, Clouse KA. Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retro-viruses 1997;13:1325-32.
83. Delmas - Beauvieu x MC, PeuchantE, Couchouron A, Constans J, Sergeant C, Simonoff M, et al The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr 1996;64:101-7.
84. Cirelli A, Ciardi M, de Simone C, Sorice F, Giordano R, Ciaralli L, et al Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 1991;24: 211-4.
85. Salonen JT, Alf than G, Huttunen JK, Pikkarainen J, Puska P. Assosiation between cardiovascular death and myocardial infarction and serum selenium in a matched pair longitudinal study. Lancet 1982;2:175-9.
86. Kloner AR, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in is chaemia - reperfusion :resolved and unresolved issue. Circulation 1989;80:1115-27.
87. Sattler W, Maiorino M, Stocker R. Reduction of HDL and LDL associated cholestrylester and phospholipids h ydroperoxides by phospholipids hydroperoxideglutathione peroxidase and ebselen (Pz 51). Arch Biochem Biophys 1994;309:224.
88. Ricetti MM, Guidi GC, Tecchio C, et al Effects of sodium selenite oninvitro interactions between platelets and endothelial cells. Int J Clin Lab Res 1999;29:80-2.
89. Kharb S. Low blood glutathione levels in acute myocardial infarction. Ind J Med Sci 2003;57:335-7.
90. Qu X, Huang K, Deng L, Xu H. Selenium deficiency induced alteration in the vascular system of the rat. Biol Trace Elem Res 2000;75:119-25.
91. Prithviraj T, Misra KP. Reversal of atheros-clerosis - fact or fiction? Cardiol Today 2000;4:97-100.
92. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr 1998;128:1845-9.
93. Shamberger RJ. Relationship of selenium to cancer: inhibitory effect of selenium on carcinogenesis. J Nat Cancer Inst 1970;44:931-6.
94. Clark LC, Combs GF, Turnbull BW. Effect of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized clinical trial. J Am Med Assoc 1996;279:1975-82.
95. Ip C, Medina D. Current concepts of selenium and mammary tumorigenesis. In: Medina D, Kidwell W, Heppner GH, Anderson E, editors. Cellular and molecular biology of mammary cancer. New York: Plenum press; 1987. P. 479.
96. Ip C, Daniel FB. Effects of selenium on 7, 12 di-methyl benzanthracene induced mammary carcinogenesis and DNA adduct formation. Cancer Res 1985;45:61-8.
97. Watrach AM, Milner JA, Watrach MA, Poirier KA. Inhibition of breast cancer cells by selenium. Cells Lett 1984;25:41-7.
98. Fico ME, Poirer KA, Watrach AM, Watrach MA, Milner JA. Differential effects of selenium on normal and neoplastic canine mammary cells. Current Res 1986;46:3384-9.
99. Klein EA. Clinical models for testing chemopreventive agents in prostate cancer and overview of SELECT: the selenium and vitamin E cancer prevention trial recent results. Cancer Res 2003;163:212-7.
100.Spygrou G, Bjornstedt M, Kumar S, Holmgren A. AP- 1 DNA binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett 1995;368:59-64.
101.Diplock AT. Antioxidants and disease prevention: an overview. Am J Clin Nutr 1991;53:189-93.
102. Spallholz JE. Selenium and the prevention of Cancer. Part II: Mechanism for the carcinostatic activity of Se compounds. Belgium: Bulletin of Se Tellurim Development Association; 2001.
103.Vadhanavikit S, Ip C, Ganther H. Metabolites of sodium selenite and methylated selenium compounds administeredat cancer chemoprevention levels in the rat. Xenobiotica 1993;23:731-45.
104.Tapeiro H, Townsend KD. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 2003;57:134-44.
105.Zeng H. Combs GF Jr. Selenium as an anticancer nutrient: roles in cell proliferation and tumour cell invasion. J Nutr Biochem 2008;19:1-7.
106.Hill KE, Zhon J, Mc Mohan WJ, Motley AK, Atkins JF, Gesteland RF, et al Deletion of selenop rotein P alters distribution of selenium in the mouse. J Biol Chem 2003;278:13640-8.
107.Agarwal A, Prabhakaran SA. Mechanism, measurement and prevention of oxidative stress in male reproductive physiology. Ind J Exp Biol 2005;43:963-74
108.Lane HW, Medina D. Mode of action of selenium inhibition of 7, 12 di-methyl benz(a)anthracene induced mouse mammary tumorigenesis. J Natl Cancer Inst 1985;75:675.
109.Hansen JC, Degachi Y. Selenium and fertiliy in animals and men: a review. Acta Vet Scan 1996;37:19-25.
110.Wantanobe T, Endo A. Effects of selenium deficiency on spermm orphology and spermatocyte chromosomes in mice. Mutat Res 1991;262:93-6.
111.Olson GE, Winfrey VP, Hill KE, Burk RF. Sequential development of flagellar defects in spermatids and epididymal spermatozoa of selenium deficientrats.Reproduction 2004;127:335-41.
112.Lenzi A, Gandini L, Lombardo F, Picardo M, Maresca V, Panfili E, et al Polyunsaturated fatty acids of germ cell membranes, glutathione and blutathione dependent enzyme - PHGPx: from basic to clinic. Contraception 2002;65:301-5.
113.Lenzi A, Picardo M, Gandini L, Lombardo F, Terminali O, Passi S, et al Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod 1994;9:2044-9.
114.Hawkes WC, Alkan Z, Wong K. Selenium supplementation does not affect testicular selenium status and semen quality in North American men. J Androl 2009;30:525-33
115.Cunningham FG, Lindheimer MD. Hyper-tension in Pregnancy: Current concepts. N Engl J Med 1992; 326:927-32.
116.Sharma JB. Benefits of Selenium during pregnancy. Obs and Gynae 2001; 6:459-462.
117.Barrington JW, Lindsay P, Names D, Smith S, Robert A. Selenium deficiency and miscarriage: a possible link ? Br J Obstet Gynaecol 1996; 2:130-132.
118.Han L, Zhou SM. Selenium and incidence of Pregnancy induced Hypertension. Clin Med J 1994; 107:870-871.
119.Sullivan JF, Blotcky AJ, Jetton MM, Hahn HKJ, Burch RE. Serum levels of selenium, calcium, copper, magnesium, manganese and zinc in various human diseases. J Nutr 1979; 109:1432-1437.
120.Ranneu T, Ladefoged K, Hylander E, Hegnhog J, Staun M. Selenium depletion in patients with gastro intestinal diseases: Are there any predictive factors? Scand J Gastroenterol 1998; 33:1057-1061.
121.Kohrle J. The trace element selenium and thyroid gland. Biochimie 1999;81:527-33
122.Hawkes WC, Keim NL. Dietary selenium intake modulates thyroid hormone and energy metabolism in men. J Nutr 2003;133:3443-8
123.Combs GF Jr, Midthune DN, Patterson KY, Canfield WK, Hill AD, Levander OA, et al Effects of selenomethionine supplementation on selenium status and thyroid hormone concentration in healthy adults. Am J Clin Nutr 2009; 89:1808-14.
124.Diplock AT. Trace elements in human health with special reference to selenium. Am J Clin Nutr 1988; 45:1313-1322.
125.Suleyman O, Mustafa N, Mesut, Vedat B, Manuel F. FA. Effects of Different Medical Treatments on Serum Copper, Selenium and Zinc Levels in Patients with Rheumatoid Arthritis. Biol Trace Elem Res 2011; 142: 447-455.
126.Peretz A, Siderova V, Neve J. Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial. Scand J Rheumato. 2001; 30(4):208-12.
127.Goldhaber SB. Trace element risk assessment: essentiality vs. toxicity. Reg Toxicol Pharmacol 2003;38:232-42
128.Institute of Medicine, Food and Nutrition Board. Dietary reference intakes:Vitamin C, Vitamin E, Selenium and carotenoids. Nat Acad Press, Washington, DC, 2000.
129.Gramm HJ, Kopf A, Bratter P. The necessity of selenium substitution in total parenteral nutrition and artificial alimentation. J Trace Elem Med Biol 1995; 9:1-12.
MR conceived the Idea, did literature search and wrote the first draft. KTM supervised the study. Both the authors contributed significantly in the submitted manuscript.
This article may be cited as: Riaz M, Mehmood KT. Selenium in Human Health and Disease: A Review. J Postgrad Med Inst 2012; 26(2): 120-33.
Lahore College For Women University Lahore - Pakistan, 2 Health Department Punjab, Lahore - Pakistan, Address for Correspondence: Dr. Munaza Riaz, Lahore College For Women University Lahore - Pakistan, E-mail: email@example.com
|Printer friendly Cite/link Email Feedback|
|Author:||Riaz, Munaza; Mehmood, Khawaja Tahir|
|Publication:||Journal of Postgraduate Medical Institute|
|Date:||Jun 30, 2012|
|Previous Article:||PATTERN OF BURNS AT LADY READING HOSPITAL, PESHAWAR.|
|Next Article:||ANALYSIS OF CHANGES IN INTRAOCULAR PRESSURE WITH CHANGES IN BODY POSITION.|